What is William Blair's Forecast for Zoetis FY2025 Earnings?

Key Points

• William Blair has reduced its FY2025 earnings estimate for Zoetis to $6.29 per share, down from $6.34, while the consensus estimate stands at $6.07.
• Zoetis is expected to pay a quarterly dividend of $0.50 per share on December 2nd, representing a 1.4% dividend yield.
• The stock consensus rating for Zoetis is "Hold," with four analysts rating it as a Buy and five as Hold.

Zoetis Inc. (NYSE:ZTS - Free Report) - Stock analysts at William Blair dropped their FY2025 earnings estimates for shares of Zoetis in a research note issued on Monday, October 13th. William Blair analyst B. Vazquez now anticipates that the company will earn $6.29 per share for the year, down from their prior forecast of $6.34. The consensus estimate for Zoetis' current full-year earnings is $6.07 per share. William Blair also issued estimates for Zoetis' FY2026 earnings at $6.78 EPS.

Several other research analysts also recently commented on the stock. Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Zoetis in a research note on Wednesday, October 8th. Piper Sandler upped their target price on shares of Zoetis from $210.00 to $215.00 and gave the stock an "overweight" rating in a research note on Monday, August 11th. Argus reiterated a "buy" rating and issued a $190.00 price target on shares of Zoetis in a report on Tuesday, September 9th. Stifel Nicolaus lowered Zoetis from a "buy" rating to a "hold" rating and lowered their price target for the company from $165.00 to $160.00 in a report on Wednesday, June 18th. Finally, Leerink Partners lowered Zoetis from an "outperform" rating to a "market perform" rating and decreased their target price for the company from $180.00 to $155.00 in a research report on Thursday, July 17th. Four equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $196.71.

Zoetis Stock Down 1.0%

NYSE:ZTS opened at $142.08 on Thursday. Zoetis has a twelve month low of $139.34 and a twelve month high of $196.55. The company has a market cap of $62.97 billion, a price-to-earnings ratio of 24.45, a price-to-earnings-growth ratio of 2.30 and a beta of 0.90. The stock has a fifty day simple moving average of $148.89 and a 200-day simple moving average of $154.03. The company has a current ratio of 1.76, a quick ratio of 1.04 and a debt-to-equity ratio of 1.05.

Zoetis (NYSE:ZTS - Get Free Report) last released its earnings results on Tuesday, August 5th. The company reported $1.76 EPS for the quarter, beating analysts' consensus estimates of $1.62 by $0.14. Zoetis had a return on equity of 56.90% and a net margin of 27.83%.The firm had revenue of $2.46 billion for the quarter, compared to analysts' expectations of $2.41 billion. During the same quarter in the prior year, the firm posted $1.56 earnings per share. The company's quarterly revenue was up 4.2% on a year-over-year basis. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS.

Institutional Trading of Zoetis

A number of institutional investors have recently made changes to their positions in ZTS. Nova Wealth Management Inc. acquired a new stake in shares of Zoetis during the first quarter worth $25,000. 1248 Management LLC acquired a new position in shares of Zoetis in the first quarter valued at about $27,000. Saudi Central Bank purchased a new stake in Zoetis in the first quarter valued at approximately $29,000. Cornerstone Planning Group LLC boosted its position in Zoetis by 79.3% in the first quarter. Cornerstone Planning Group LLC now owns 199 shares of the company's stock valued at $30,000 after buying an additional 88 shares during the last quarter. Finally, REAP Financial Group LLC lifted its stake in Zoetis by 201.5% during the 2nd quarter. REAP Financial Group LLC now owns 196 shares of the company's stock valued at $31,000 after acquiring an additional 131 shares during the period. Institutional investors and hedge funds own 92.80% of the company's stock.

Zoetis Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 2nd. Investors of record on Friday, October 31st will be paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 1.4%. The ex-dividend date is Friday, October 31st. Zoetis's payout ratio is 34.42%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.